Author Teunissen, Charlotte E.
-
2012 | Review
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
del Campo, M.; Mollenhauer, B.; Bertolotto, A.; Engelborghs, S.; Hampel, H.; Simonsen, A. H.& Kapaki, E. et al. (2012)
Biomarkers in Medicine, 6(4) pp. 419-430.
Future Medicine Ltd. DOI: https://doi.org/10.2217/BMM.12.46
Details DOI PMID PMC WoS
-
2014 | Journal Article
The influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease
Louwersheimer, E.; Ramirez, A.; Cruchaga, C.; Becker, T.; Kornhuber, J. ; Peters, O. & Heilmann, S. et al. (2014)
Neurobiology of Aging, 36(3) pp. 1605.e13-1605.e20. DOI: https://doi.org/10.1016/j.neurobiolaging.2014.12.007
Details DOI
-
2014 | Journal Article
SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease
Ramirez, A.; van der Flier, W. M.; Herold, C.; Ramonet, D.; Heilmann, S.; Lewczuk, P. & Popp, J. et al. (2014)
Human Molecular Genetics, 23(24) pp. 6644-6658. DOI: https://doi.org/10.1093/hmg/ddu372
Details DOI
-
2014 | Journal Article
Biobanking of CSF: International standardization to optimize biomarker development
Teunissen, C. E.; Tumani, H.; Engelborghs, S. & Mollenhauer, B. (2014)
Clinical Biochemistry, 47(4-5) pp. 288-292. DOI: https://doi.org/10.1016/j.clinbiochem.2013.12.024
Details DOI PMID PMC WoS
-
2015 | Journal Article |
The central biobank and virtual biobank of BiOMarKaPD: a resource for studies on neurodegenerative diseases
Reijs, B. L. R.; Teunissen, C. E.; Goncharenko, N.; Betsou, F.; Blennow, K.; Baldeiras, I. & Brosseron, F. et al. (2015)
Frontiers in Neurology, 6 art. UNSP 216. DOI: https://doi.org/10.3389/fneur.2015.00216
Details DOI PMID PMC WoS
-
2015 | Journal Article |
A practical guide to immunoassay method validation
Andreasson, U.; Perret-Liaudet, A.; van Waalwijk van Doorn, L. J. C.; Blennow, K.; Chiasserini, D.; Engelborghs, S. & Fladby, T. et al. (2015)
Frontiers in Neurology, 6 art. UNSP 179. DOI: https://doi.org/10.3389/fneur.2015.00179
Details DOI PMID PMC WoS
-
2016 | Journal Article
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
Lelental, N.; Brandner, S.; Kofanova, O.; Blennow, K.; Zetterberg, H.; Andreasson, U. & Engelborghs, S. et al. (2016)
Journal of Alzheimer's Disease, 52(1) pp. 51-64. DOI: https://doi.org/10.3233/jad-150883
Details DOI
-
2016 | Journal Article
Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases
van Waalwijk van Doorn, L. J. C.; Koel-Simmelink, M. J.; Haußmann, U.; Klafki, H. ; Struyfs, H.; Linning, P. & Knölker, H.-J. et al. (2016)
Journal of Neurochemistry, 137(1) pp. 112-121. DOI: https://doi.org/10.1111/jnc.13527
Details DOI PMID PMC
-
2016 | Journal Article
Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort
Steenoven, I. van; Aarsland, D.; Weintraub, D.; Londos, E.; Blanc, F.; van der Flier, W. M. & Teunissen, C. E. et al. (2016)
Journal of Alzheimer s Disease, 54(1) pp. 287-295. DOI: https://doi.org/10.3233/JAD-160322
Details DOI PMID PMC WoS
-
2016 | Journal Article
Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration
Miller, A.-M.; Rutkowska, A.; Bahl, J. M. C.; Herukka, S.-K.; Koel-Simmelink, M. J. A.; Kruse, N. & Mollenhauer, B. et al. (2016)
Bioanalysis, 8(21) pp. 2243-2254. DOI: https://doi.org/10.4155/bio-2016-0114
Details DOI PMID PMC WoS